Financial Statements · Financial Reporting

NovoTar Biotech OÜ

Official identifier 11349409Record date 31 Dec 2021
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2021
Period start
1 Jan 2021
Submitted date
24 Apr 2022

Report

Consolidated
No
Audited
No

Financial metrics

StatementMetricValue
Balance sheetAssets104,398
Balance sheetCash and cash equivalents74,540
Balance sheetCurrent assets104,398
Balance sheetCurrent liabilities425
Balance sheetEquity103,973
Balance sheetShare capital at nominal value2,877
Balance sheetRetained earnings (loss) from previous periods78,606
Income statement scheme 1Revenue241,325
Income statement scheme 1Annual period profit / loss22,202
Income statement scheme 1Operating profit (loss)22,202
Income statement scheme 1Profit (loss) before income tax22,202
Profit distribution proposalRetained earnings (loss) from previous periods78,606
Kasumi jaotamise otsusRetained earnings (loss) from previous periods78,606
Note: Labour costsEmployees0

Linked company

Company: NovoTar Biotech OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements